Clinical Trials

Showing trials with last updates posted in 2020.

NCT03739606 | WITHDRAWN | PHASE2
0 participants

Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2020-12-17
Start Date:
2020-10-20
Completion:
2020-10-20
Conditions
  • Acute Biphenotypic Leukemia
  • Acute Leukemia
  • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Hairy Cell Leukemia
  • Interleukin-3 Receptor Subunit Alpha Positive
  • Recurrent Acute Lymphoblastic Leukemia
  • Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm
  • Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Recurrent Hematologic Malignancy
  • Recurrent Hodgkin Lymphoma
  • Refractory Acute Lymphoblastic Leukemia
  • Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm
  • Refractory Hematologic Malignancy
  • Refractory Hodgkin Lymphoma
  • Systemic Mastocytosis
Interventions
  • BIOLOGICAL
No Results Yet
NCT03677336 | COMPLETED | PHASE4
30 participants

Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in IVF/ICSI

Study Type:
INTERVENTIONAL
Last Updated:
2020-12-17
Start Date:
2019-05-01
Completion:
2020-08-24
Conditions
  • Infertility, Female
  • Infertility
  • Genital Diseases, Male
  • Genital Diseases, Female
  • Progesterone
  • Dydrogesterone
  • Hormones
  • Hormones, Hormone Substitutes, and Hormone Antagonists
  • Physiological Effects of Drugs
  • Progestins
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page